ArticleScientific reports2021

Anti-cancer efficacy including Rb-deficient tumors and VHL-independent HIF1α proteasomal destabilization by dual targeting of CDK1 or CDK4/6 and HSP90.

Shuai Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.